-
公开(公告)号:US5736134A
公开(公告)日:1998-04-07
申请号:US244773
申请日:1994-08-17
IPC分类号: A61K38/00 , C12N1/21 , C12N9/72 , C12N15/10 , C12N15/67 , C12N15/71 , A61K38/48 , C07H21/04 , C12N9/48
CPC分类号: C12N9/6462 , C12N15/102 , C12N15/67 , C12N15/71 , C12N9/6459 , C12Y304/21069 , C12Y304/21073 , A61K38/00
摘要: Biologically active variant tissue plasminogen activators are disclosed. The disclosure focuses on position 276 variants that exhibit enhanced fibrin specificity.
摘要翻译: PCT No.PCT / US92 / 10677 Sec。 371日期:1994年8月17日 102(e)日期1994年8月17日PCT提交1992年12月14日PCT公布。 出版物WO93 / 12225 日期1994年6月24日公开了生物活性变体组织纤溶酶原激活剂。 本公开集中于显示增强的纤维蛋白特异性的位置276变体。
-
公开(公告)号:US5714372A
公开(公告)日:1998-02-03
申请号:US306928
申请日:1994-09-15
CPC分类号: C12N9/6459 , C12Y304/21069 , A61K38/00
摘要: Biologically active mutant tissue plasminogen activators are disclosed wherein site directed mutagenesis, for example, of a two-chain activation site renders said mutants resistant to conversion to the two-chain form. In addition, mutant tissue plasminogen activators are disclosed which have amino acid substitutions or deletions in the region of positions 274-277, which may or may not be resistant to conversion to the two-chain form, but show enhanced fibrin specificity relative to wild-type tissue plasminogen activator.
摘要翻译: 公开了生物活性突变组织纤溶酶原激活剂,其中例如双链激活位点的定点诱变使所述突变体对转化为双链形式具有抗性。 此外,公开了突变组织纤溶酶原激活剂,其在位置274-277的区域具有氨基酸取代或缺失,其可能或可能不耐转化为双链形式,但相对于野生型的纤维蛋白特异性显示出增强的纤维蛋白特异性, 型组织纤溶酶原激活物。
-
23.
公开(公告)号:US5633076A
公开(公告)日:1997-05-27
申请号:US154019
申请日:1993-11-16
申请人: Herman A. DeBoer , Rein Strijker , Herbert L. Heyneker , Gerard Platenburg , Sang H. Lee , Frank Pieper , Paul J. A. Krimpenfort
发明人: Herman A. DeBoer , Rein Strijker , Herbert L. Heyneker , Gerard Platenburg , Sang H. Lee , Frank Pieper , Paul J. A. Krimpenfort
IPC分类号: A01K67/027 , A23C9/20 , C07K14/47 , C07K14/765 , C07K14/79 , C12N9/36 , C12N9/64 , C12N15/12 , C12N15/85 , C12N15/00 , C12N5/00
CPC分类号: C12N15/8509 , A01K67/0275 , A01K67/0278 , A23C9/20 , C07K14/4732 , C07K14/765 , C07K14/79 , C12N15/85 , C12N9/2462 , C12N9/6464 , C12Y304/21069 , A01K2207/15 , A01K2217/00 , A01K2217/05 , A01K2217/072 , A01K2227/101 , A01K2227/105 , A01K2267/01 , C12N2800/30 , C12N2830/008 , C12N2830/15 , C12N2830/42 , C12N2830/85 , C12N2840/44
摘要: A method is disclosed for the production of a transgenic bovine or a transgenic bovine embryo comprising obtaining an ovum from bovine ovaries, maturing the ovum in vitro, fertilizing the mature ovum or ova in vitro to form a zygote, introducing a transgene into the zygote in vitro and maturing the zygote to a preimplantation stage embryo in vitro. To produce the transgenic bovine, the embryo is transplanted into a recipient female bovine, wherein the female bovine gestates the embryo to produce a transgenic bovine.
摘要翻译: 公开了用于产生转基因牛或转基因牛胚胎的方法,其包括从牛卵巢获得卵子,在体外成熟卵子,在体外对成熟卵子或卵进行受精以形成受精卵,将转基因引入受精卵中 将体外培养和合并成熟胚胎到胚胎移植前胚胎体外。 为了产生转基因牛,将胚胎移植到接受者雌性牛中,其中雌性牛孕育胚胎以产生转基因牛。
-
24.
公开(公告)号:US5403708A
公开(公告)日:1995-04-04
申请号:US909165
申请日:1992-07-06
CPC分类号: C12Q1/6827 , C07H21/00 , C12Q1/6862 , C12Q1/6869 , Y10T436/143333
摘要: Methods and compositions for forming ligation product hybridized to a nucleic acid template. The ligation product is formed by contacting a nucleic acid template with a primer capable of hybridizing to the template to form a primed template. The primed template is then contacted with a pool of random extension oligonucleotides of length N and an enzyme system. The enzyme system is capable of covalently linking the primer to an extension oligonucleotide adjacently hybridized to it and one or more other extension oligonucleotides adjacently hybridized to the ligation product defined by covalently linked ligation primer and one or more extension oligonucleotides. When covalently linked, the ligation product is hybridized to the nucleic acid template. Modifications permit the determination of the nucleotide sequence of one or more members of a first set of target nucleotide residues in the nucleic acid template that are spaced at intervals of N nucleotides. In such sequencing methods, labeled ligation product is formed wherein the position and type of label incorporated into the labeled ligation product provides information concerning the nucleotide residue in the nucleic acid template with which the labeled nucleotide residue is base paired. The compositions comprise a pool of oligonucleotides of a predetermined length N containing at least one differentially labeled sequencing nucleotide residue at a predetermined position and random nucleotide residues at each of the other nucleotide positions.
摘要翻译: 用于形成与核酸模板杂交的连接产物的方法和组合物。 通过使核酸模板与能够与模板杂交的引物接触以形成引发的模板来形成连接产物。 然后将引发的模板与长度为N和酶系统的随机延伸寡核苷酸库接触。 酶系统能够共价连接引物与与其相邻杂交的延伸寡核苷酸和与由共价连接的连接引物和一个或多个延伸寡核苷酸定义的连接产物相邻杂交的一个或多个其它延伸寡核苷酸。 当共价连接时,连接产物与核酸模板杂交。 修饰允许确定间隔N个核苷酸的核酸模板中第一组靶核苷酸残基的一个或多个成员的核苷酸序列。 在这样的测序方法中,形成标记的连接产物,其中结合到标记的连接产物中的标记的位置和类型提供了与标记的核苷酸残基是碱基配对的核酸模板中的核苷酸残基有关的信息。 组合物包含预定长度N的寡核苷酸库,其在预定位置含有至少一个差异标记的测序核苷酸残基,并且在每个其它核苷酸位置处含有随机核苷酸残基。
-
公开(公告)号:US4663283A
公开(公告)日:1987-05-05
申请号:US543682
申请日:1983-10-20
IPC分类号: C07K14/61 , C07K14/655 , C12N15/10 , C12N15/66 , C12N15/71 , C12P21/02 , C12P19/34 , C12N15/00
CPC分类号: C12N15/71 , C07K14/61 , C07K14/655 , C12N15/10 , C12N15/66 , C12P21/02 , C07K2319/00 , C07K2319/02 , C07K2319/75
摘要: A method of altering double stranded DNA comprising converting double stranded DNA to single stranded DNA in a region surrounding a selected cleavage site, hybridizing a complimentary primer to the single stranded region formed in the previous step, and restoring enzymatically the second strand which had been eliminated.
摘要翻译: 一种改变双链DNA的方法,包括在选定的切割位点周围的区域中将双链DNA转化为单链DNA,将互补引物与前述步骤中形成的单链区域杂交,并且酶消化已经被消除的第二链 。
-
26.
公开(公告)号:US06333174B1
公开(公告)日:2001-12-25
申请号:US08482321
申请日:1995-06-06
IPC分类号: C12N1563
CPC分类号: C12N15/10 , C07K14/61 , C07K14/655 , C07K2319/00 , C07K2319/02 , C07K2319/75 , C12N15/62 , C12N15/71 , C12P19/34
摘要: Methods for the controllable expression in high yields of heterologous proteins under the control of a modified tryptophan promoter-operator system are disclosed. The system employed involves sequential resort to tryptophan repression and derepression, as well as deletion of an attenuator function native to the tryptophan operon. Means are also disclosed for effecting deletions at any given point within a gene fragment and for the ready identification of transformant bacteria via triple ligation procedures.
摘要翻译: 公开了在修饰的色氨酸启动子 - 操作系统的控制下可高表达异源蛋白质的方法。 所用的系统涉及顺序地采用色氨酸抑制和去阻遏,以及删除色氨酸操纵子原生的衰减子功能。 还公开了用于在基因片段内的任何给定点进行缺失以及通过三连接方法准备鉴定转化细菌的方法。
-
公开(公告)号:US5795745A
公开(公告)日:1998-08-18
申请号:US457282
申请日:1995-06-01
IPC分类号: C12N15/00 , A61K38/27 , C07G99/00 , C07H21/00 , C07H21/04 , C07K14/00 , C07K14/575 , C07K14/61 , C12N20060101 , C12N1/20 , C12N1/21 , C12N15/09 , C12N15/10 , C12N15/18 , C12N15/62 , C12N15/63 , C12N15/64 , C12N15/66 , C12N15/70 , C12N15/72 , C12P20060101 , C12P19/34 , C12P21/00 , C12P21/02 , C12R1/125 , C12R1/19 , C12R1/42 , C12R1/46
CPC分类号: C12N15/66 , C07K14/61 , C12N15/10 , C12N15/62 , C12N15/70 , C07K2319/00 , C07K2319/02 , C07K2319/50 , C07K2319/75 , Y10S930/12
摘要: Described are methods and means for the construction and microbial expression of quasi-synthetic genes arising from the combination of organic synthesis and enzymatic reverse transcription from messenger RNA sequences incomplete from the standpoint of the desired protein product. Preferred products of expression lack bio-inactivating leader sequences common in eukaryotic expression products but problematic with regard to microbial cleavage to yield bioactive material. Illustrative is a preferred embodiment in which a gene coding for human growth hormone (useful in, e.g., treatment of hypopituitary dwarfism) is constructed and expressed.
-
公开(公告)号:US5489529A
公开(公告)日:1996-02-06
申请号:US093383
申请日:1993-07-19
CPC分类号: C12N15/70
摘要: High-level expression of bovine growth hormone is achieved using DNA encoding bovine growth hormone which, when transcribed, produces messenger RNA (mRNA) that at its 5' end is substantially free of secondary structure that is capable of interfering with translation of the mRNA.
摘要翻译: 使用编码牛生长激素的DNA实现牛生长激素的高水平表达,其在转录时产生信使RNA(mRNA),其在5'端基本上不含能够干扰mRNA翻译的二级结构。
-
公开(公告)号:US5112755A
公开(公告)日:1992-05-12
申请号:US221487
申请日:1988-07-19
CPC分类号: C12N9/6462 , C12Y304/21073 , A61K38/00
摘要: Human urokinase is produced using recombinant DNA techniques. The invention disclosed thus enables the production of urokinase free of contaminants with which it is ordinarily associated in its native cellular environment. Methods, expression vehicles and various host cells useful in its production are also disclosed.
摘要翻译: 使用重组DNA技术产生人尿激酶。 因此,所公开的本发明能够生产没有与其天然细胞环境通常相关的污染物的尿激酶。 还公开了可用于其生产的方法,表达载体和各种宿主细胞。
-
公开(公告)号:US4816567A
公开(公告)日:1989-03-28
申请号:US483457
申请日:1983-04-08
IPC分类号: G01N33/531 , A61K39/395 , C07K7/06 , C07K14/00 , C07K16/00 , C07K16/18 , C07K16/30 , C07K16/46 , C07K19/00 , C12N1/00 , C12N1/15 , C12N1/19 , C12N1/21 , C12N5/10 , C12N15/09 , C12N15/13 , C12N15/63 , C12N15/81 , C12P21/02 , C12P21/08 , C12R1/19 , G01N33/577 , C07K15/14 , C07K15/06 , C12N1/20 , C12N15/00 , C12P21/00
CPC分类号: C12N15/63 , C07K16/3007 , C07K16/462 , C12N15/81 , C07K2317/24 , C07K2319/00 , C07K2319/02 , C07K2319/30 , Y10S530/866 , Y10S530/867 , Y10S930/30
摘要: Altered and native immunoglobulins, including constant-variable region chimeras, are prepared in recombinant cell culture. The immunoglobulins contain variable regions which are immunologically capable of binding predetermined antigens. Methods are provided for refolding directly expressed immunoglobulins into immunologically active form.
摘要翻译: 在重组细胞培养物中制备改变的天然免疫球蛋白,包括恒定可变区嵌合体。 免疫球蛋白含有可免疫学上能够结合预定抗原的可变区。 提供了将直接表达的免疫球蛋白重折叠成免疫活性形式的方法。
-
-
-
-
-
-
-
-
-